We support Salix through strategic corporate and product-related communications (media and social channels) that aim to drive visibilily, reputation and engagement with key stakeholders nationally, locally and online. From media relations to awareness programs to sponsorship activations, the Coyne team has managed to help elevate Salix’s presence.

Coyne PR supports Salix through strategic corporate media relations, with an emphasis on featuring the company’s general manager to showcase its commitment to the gastroenterological category. The team launched the @SalixPharma Twitter handle, developed community guidelines and response protocol, and created a new company newsletter, to keep key stakeholders informed and engaged on company programs.
To enhance visibility of Salix’s marquis brand, Xifaxan, Coyne PR initiated a multi-pronged campaign. Featuring a partnership with a nationally renowned expert from Cedars-Sinai Medical Center, we leveraged research pointing to bacteria in the small intestine as a root cause of most IBS-D symptoms - a departure from conventional theory. We brought the research to life by launching a virtual reality tool that journeys through the gut to explore the causes of IBS-D, and re-introduced Salix to gastroenterology media to reaffirm its commitment to patients and physicians, specifically the role gut microbiota may play in creating symptoms for patients.
To raise awareness for Relistor, Salix’s treatment for opioid induced constipation (OIC) – and to shed light on the burden associated with it – Coyne PR leveraged a partnership with the U.S. Pain Foundation to develop the “Painstipation” survey, focused on understanding the clinical and behavioral experiences of chronic pain patients who suffer from constipation as a result of opioid therapy. Launched at PainWEEK 2017, the largest U.S. pain conference for frontline clinicians, the patient survey informed physicians who treat chronic pain patients about the struggles with OIC to prompt more informed conversations, and provide patients with faster, more reliable relief.
To support awareness of its Irritable Bowel Syndrome (IBS) and Ulcerative Colitis (UC) brand Uceris, Coyne PR initiated Salix’s inaugural engagement with online influencers. The team engaged high-profile patient bloggers who speak on IBS and UC, with the goal of establishing a brand halo around Salix and its commitment to treating gastrointestinal issues. The bloggers highlighted Salix’s offerings, and promoted the company’s partnership with the Crohn’s and Colitis Foundation to encourage their followers to participate in Take Steps for Crohn’s & Colitis WALKS across the country. Most importantly, this initial engagement laid the foundation for ongoing and meaningful relationships between the brand and key influencers.